Board Meeting30 Sept 2026, 07:30 pm
Novartis India Board Meeting on Nov 3 to Approve Q2 FY27 Results
AI Summary
Novartis India Limited has announced that its Board of Directors will convene on Tuesday, November 03, 2026. The primary agenda item is to consider and approve the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. Concurrently, the company is implementing a closure of the trading window for its designated persons, insiders, connected persons, and their immediate relatives. This closure will be effective from October 01, 2026, and will be lifted 48 hours after the financial results are officially declared to the stock exchange. This measure is in compliance with SEBI regulations concerning insider trading.
Key Highlights
- Board meeting scheduled for November 3, 2026.
- To consider and approve Unaudited Financial Results for Q2 FY27.
- Trading window to close from October 1, 2026.
- Trading window reopens 48 hours post results declaration.
- Measures comply with SEBI insider trading regulations.
Price Impact
More from NOVARTIND